These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 12678232

  • 41. Collaborative assay of a proposed international standard for tetanus toxoid (adsorbed).
    van Ramshorst JD, Sundaresan TK.
    Bull World Health Organ; 1972; 46(1):53-66. PubMed ID: 4537335
    [Abstract] [Full Text] [Related]

  • 42. The use of alternatives to animal tests in developing countries.
    Hong HA, Hendriks J.
    Dev Biol Stand; 1999; 101():209-14. PubMed ID: 10566795
    [Abstract] [Full Text] [Related]

  • 43. [Determination of tetanus toxin and toxoid by ELISA using monoclonal antibodies].
    Burkin MA, Sviridov VV, Perelygina OV.
    Prikl Biokhim Mikrobiol; 2004; 40(4):478-84. PubMed ID: 15455723
    [Abstract] [Full Text] [Related]

  • 44. Statement on the application of the ToBI test for batch potency testing of tetanus vaccines for human use.
    Altern Lab Anim; 2001; 29(2):94-6. PubMed ID: 11379537
    [No Abstract] [Full Text] [Related]

  • 45. Are potency tests for tetanus vaccines really necessary?
    Knight PA.
    Dev Biol Stand; 1986; 64():39-45. PubMed ID: 3792656
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Statistical evaluation of numbers of animals to be used in vaccine potency testing: a practical approach.
    Akkermans AM, Hendriksen CF.
    Dev Biol Stand; 1999; 101():255-60. PubMed ID: 10566799
    [Abstract] [Full Text] [Related]

  • 48. Validation of an anti-PA-ELISA for the potency testing of anthrax vaccine in mice.
    Pombo M, Berthold I, Gingrich E, Jaramillo M, Leef M, Sirota L, Hsu H, Arciniega J.
    Biologicals; 2004 Sep; 32(3):157-63. PubMed ID: 15536047
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Validation of in vitro potency assays for tetanus immunoglobulin.
    Gross S, Volkers P, Eckert-Ziem M, Kuschel S, Schäffner G.
    Pharmeuropa Bio; 2006 Nov; 2006(1):1-6. PubMed ID: 17270126
    [Abstract] [Full Text] [Related]

  • 51. Statement on the application of the ELISA procedure for batch potency testing of tetanus vaccines for human use.
    Altern Lab Anim; 2001 Nov; 29(2):93-4. PubMed ID: 11351964
    [No Abstract] [Full Text] [Related]

  • 52. Use of filter paper discs as substrate for collection and storage of blood samples for screening of anti-tetanus toxoid antibodies.
    Ganju L, Gaur A, Talwar GP.
    Diagn Clin Immunol; 1988 Nov; 5(5):262-5. PubMed ID: 3359568
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement.
    Hendriksen CF.
    Expert Rev Vaccines; 2009 Mar; 8(3):313-22. PubMed ID: 19249973
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
    Buchheit KH, Daas A, Stalder J.
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.